Showing results (151-160 of 194) with videos related to

Sort By:
Pageof 20
Epilepsia|June 26, 2026
Intermittent fasting with medium-chain triglycerides in drug-resistant epilepsy: A pilot crossover trialWiebke Hahn, Emily Falk, Ayla Balzter, et al.
Journal of Veterinary Internal Medicine|July 3, 2017
Effects of Benazepril on Survival of Dogs with Chronic Kidney Disease: A Multicenter, Randomized, Blinded, Placebo-Controlled Clinical TrialJ N King, A Font, J-F Rousselot, et al.
AIDS (London, England)|June 15, 2021
Persistently lower bone mass and bone turnover among South African children living with well controlled HIVYanhan Shen, Stephanie Shiau, Renate Strehlau, et al.
AIDS Care|December 21, 2021
Disclosure to South African children about their own HIV status over timeMelody Wu, Stephanie Shiau, Renate Strehlau, et al.
The Pediatric Infectious Disease Journal|September 2, 2016
Effect of Lopinavir and Nevirapine Concentrations on Viral Outcomes in Protease Inhibitor-experienced HIV-infected ChildrenRetsilisitsoe R Moholisa, Michael Schomaker, Louise Kuhn, et al.
AIDS Care|August 30, 2016
Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV statusPamela M Murnane, Stacy-Lee Sigamoney, Francoise Pinillos, et al.
The Lancet. Infectious Diseases|March 20, 2012
Switching children previously exposed to nevirapine to nevirapine-based treatment after initial suppression with a protease-inhibitor-based regimen: long-term follow-up of a randomised, open-label trialLouise Kuhn, Ashraf Coovadia, Renate Strehlau, et al.
The Lancet. HIV|November 13, 2018
12-month outcomes of HIV-infected infants identified at birth at one maternity site in Johannesburg, South Africa: an observational cohort studyKarl-Günter Technau, Renate Strehlau, Faeezah Patel, et al.
The Journal of Pediatrics|July 27, 2020
Behavioral Functioning and Quality of Life in South African Children Living with HIV on Antiretroviral TherapyStephanie Shiau, Henry Evans, Renate Strehlau, et al.
Journal of the International AIDS Society|January 31, 2025
Pharmacokinetics, safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide in children with HIV aged from 2 years and weighing at least 14 kgEva Natukunda, Aditya H Gaur, Pope Kosalaraksa, et al.
Pageof 20